ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

August 30, 2013

National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis

August 23, 1974

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978